Pharmacometrics Positions at Model Answers Pty Ltd, Australia

1 messages 1 people Latest: Oct 17, 2013
Dear Colleagues, Model Answers Pty Ltd is seeking applications for pharmacometricians / senior pharmacometricians to join their team in Brisbane, Australia. The successful candidate(s) will work with an inspiring group that provides a range of pharmacometric solutions to a global client network. The positions are suited to highly motivated individuals who are looking for a challenging opportunity to facilitate model based drug development and academic advancement. Applicants should have excellent time management and communication skills, and be able to innovatively support pharmacometric development. Applicants should also have a strong programming background in R or SPlus, and demonstrated modelling experience using NONMEM / BUGS together with a PhD or equivalent qualification/experience in the pharmacometrics area. The positions are located in the central business district of Brisbane, Australia, renowned for a superb sub-tropical climate with an emphasis on an outdoor lifestyle. Appropriate visa sponsorship (457 for Professional, Scientific and Technical Services) will be provided by Model Answers Pty Ltd. Interested applicants should contact Bruce Green at [email protected] or refer to the website (www.model-a.com.au) for further information about the company. Best wishes, Bruce ___________________________________________________________________________________ Bruce Green, Founder and Director, Model Answers Pty Ltd Co-Founder and Clinical Director, DoseMe Pty Ltd Tel: +61 7 3232 1124 www.model-a.com.au www.DoseMe.com.au This e-mail, together with any attachments, is confidential and intended for the named recipient(s) only. If you are not the intended recipient or have received this message in error, you are asked to immediately notify the sender and delete this message and any copies of this message from your computer system network and destroy any printed copies of this email. Any form of unauthorised disclosure, modification, distribution, publication or use of this e-mail message is prohibited. ___________________________________________________________________________________